MedKoo Cat#: 530656 | Name: AG-7404
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

AG-7404 is a potent protease inhibitor with Anti-poliovirus activity. AG-7404 is active against all virus with EC50 values ranging from 0.080 to 0.674 μM. AG-7404 was fully active against all V-073-resistant variants, with EC₅₀ values ranging from 0.218 to 0.819 μM, compared to values of 0.202-0.407 μM for the V-073-susceptible parental strains. In vitro drug combination experiments demonstrated synergy between AG-7404 and either V-073 or BTA798, whereas the combination of the two capsid inhibitors acted additively.

Chemical Structure

AG-7404
AG-7404
CAS#343565-99-1

Theoretical Analysis

MedKoo Cat#: 530656

Name: AG-7404

CAS#: 343565-99-1

Chemical Formula: C26H29N5O7

Exact Mass: 523.2067

Molecular Weight: 523.55

Elemental Analysis: C, 59.65; H, 5.58; N, 13.38; O, 21.39

Price and Availability

Size Price Availability Quantity
1mg USD 150.00 Ready to ship
5mg USD 550.00 Ready to ship
10mg USD 950.00 Ready to ship
25mg USD 1,650.00 Ready to Ship
50mg USD 2,950.00 Ready to Ship
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
AG-7404; AG 7404; AG7404; V 7404; V-7404; V7404;
IUPAC/Chemical Name
(S,E)-ethyl 4-((S)-2-(3-(5-methylisoxazole-3-carboxamido)-2-oxopyridin-1(2H)-yl)pent-4-ynamido)-5-((S)-2-oxopyrrolidin-3-yl)pent-2-enoate
InChi Key
QCUZOJBYWQPLIN-BNMFZAHFSA-N
InChi Code
InChI=1S/C26H29N5O7/c1-4-7-21(31-13-6-8-19(26(31)36)29-24(34)20-14-16(3)38-30-20)25(35)28-18(9-10-22(32)37-5-2)15-17-11-12-27-23(17)33/h1,6,8-10,13-14,17-18,21H,5,7,11-12,15H2,2-3H3,(H,27,33)(H,28,35)(H,29,34)/b10-9+/t17-,18+,21-/m0/s1
SMILES Code
O=C(OCC)/C=C/[C@@H](NC([C@@H](N1C=CC=C(NC(C2=NOC(C)=C2)=O)C1=O)CC#C)=O)C[C@H]3C(NCC3)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info
Biological target:
AG-7404 is a potent protease inhibitor with Anti-poliovirus activity.
In vitro activity:
The spectrum of AG-7404 and BTA798 activity against a panel of 45 polioviruses was evaluated in a cell culture CPE assay. AG-7404 was active against all viruses in this panel, with EC50 values ranging from 0.080 to 0.674 μM. Ninety percent of all polioviruses tested were inhibited by AG-7404 at an EC50 value of ⩽0.446 μM (MIC90 = 0.446 μM) and by BTA798 at an EC50 value of ⩽0.236 μM (MIC90 = 0.236 μM). Reference: Antiviral Res. 2013 May;98(2):186-91. https://pubmed.ncbi.nlm.nih.gov/23499651/
In vivo activity:
TBD
Solvent mg/mL mM
Solubility
DMSO 0.0 0.00
Note: There can be variations in solubility for the same chemical from different vendors or different batches from the same vendor. The following factors can affect the solubility of the same chemical: solvent used for crystallization, residual solvent content, polymorphism, salt versus free form, degree of hydration, solvent temperature. Please use the solubility data as a reference only. Warming and sonication will facilitate dissolving. Still have questions? Please contact our Technical Support scientists.

Preparing Stock Solutions

The following data is based on the product molecular weight 523.55 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
1. Rhoden E, Liu HM, Wang-Chern SW, Oberste MS. Anti-poliovirus activity of protease inhibitor AG-7404, and assessment of in vitro activity in combination with antiviral capsid inhibitor compounds. Antiviral Res. 2013 May;98(2):186-91. doi: 10.1016/j.antiviral.2013.03.003. Epub 2013 Mar 13. Erratum in: Antiviral Res. 2013 Sep;99(3):436. PMID: 23499651.
In vitro protocol:
1. Rhoden E, Liu HM, Wang-Chern SW, Oberste MS. Anti-poliovirus activity of protease inhibitor AG-7404, and assessment of in vitro activity in combination with antiviral capsid inhibitor compounds. Antiviral Res. 2013 May;98(2):186-91. doi: 10.1016/j.antiviral.2013.03.003. Epub 2013 Mar 13. Erratum in: Antiviral Res. 2013 Sep;99(3):436. PMID: 23499651.
In vivo protocol:
TBD
1: Rhoden E, Liu HM, Wang-Chern SW, Oberste MS. Anti-poliovirus activity of protease inhibitor AG-7404, and assessment of in vitro activity in combination with antiviral capsid inhibitor compounds. Antiviral Res. 2013 May;98(2):186-91. doi: 10.1016/j.antiviral.2013.03.003. Epub 2013 Mar 13. Erratum in: Antiviral Res. 2013 Sep;99(3):436. PubMed PMID: 23499651.
Vincent N. Azzolino, Vincent N. Azzolino; Ala M. Shaqra,Akbar Ali; Nese Kurt Yilmaz; and Celia A. Schiffer. Structural Analysis of Inhibitor Binding to Enterovirus-D68 3C Protease. Viruses 2025, 17(1), 75; https://doi.org/10.3390/v17010075